Updates are available Correction dated 2024-07-06
Click to view Correction: https://doi.org/10.1186/s13195-024-01518-4
-
Authors
Rasing, Ingeborg
Voigt, Sabine
Koemans, Emma A.
de Kort, Anna M.
van Harten, Thijs W.
van Etten, Ellis S.
van Zwet, Erik W.
Stoops, Erik
Francois, Cindy
Kuiperij, H. Bea
Klijn, Catharina J.M.
Schreuder, Floris H.B.M.
van der Weerd, Louise
van Osch, Matthias J.P.
van Walderveen, Marianne A.A.
Verbeek, Marcel M.
Terwindt, Gisela M.
Wermer, Marieke J.H.
-
Funding
Funding for this research was provided by:
Dutch Heart Foundation (2012 T077, 2019 T060, 2016 T086)
the Netherlands Organisation for Health Research and Development (ZonMw; 015008048, ZonMW, nr. 733050822)
National Institutes of Health, USA (5R01NS104147-02)
The Galen and Hilary Weston Foundation (NR170024)
The Netherlands Organization for Health Research and Development (DR-2019-00299)
Alzheimer’s Disease Research program of the BrightFocus Foundation (A2021007F)
from the Netherlands Organisation for Health Research and Development (91717337)
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 12 April 2024
First Online: 23 April 2024
Change Date: 6 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13195-024-01518-4
Declarations
:
: The study was approved by the ethics committee of the Leiden University Medical Center (reference number NL62670.058.17 (AURORA) and NL63256.058.17 (FOCAS)) and the Radboud University Medical Center (reference number 2017–3810 (BIONIC) and 2014 − 1401 (CAVIA)).Written informed consent was obtained from all D-CAA and sCAA study participants before enrollment. The serum and CSF samples of the RUMC control cohort were obtained as part of diagnostic workup. All samples were coded and used with the consent of the participants.
: Not applicable.
: The authors declare no competing interests.
